| Active substance |
Peptide |
| Also known as |
DAC:GRF, Drug Affinity Complex: Growth Hormone Releasing Factor |
| Blood pressure |
No significant impact |
| Chemical name |
L-Tyrosyl-D-alanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-valyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-glutamyl-L-seryl-L-alpha-glutamyl-L-valyl-L-valyl-L-tryptophyl-L-alphaglycyl-L-alphaglycyl-L-alphaglycyl-L-lysyl-L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-glutamyl-L-seryl-L-alphaglycyl-L-alphaglycyl-L-lysyl-L-alphaglycyl-L-histidyl-L-leucyl-L-isoleucyl-L-alphaglycyl-L-lysyl-L-leucyl-L-leucyl-L-alpha-glutamyl-L-valyl-L-alpha-glutamyl-L-arginyl-L-arginyl-L-leucyl |
| Dosage (medical) |
Typically 1-2 mg once or twice a week |
| Dosage (sports) |
1-2 mg two times a week |
| Effects |
Increased muscle growth, enhanced fat loss, improved skin elasticity, strengthened immune system |
| Formula |
C152H252N44O42 |
| Half-life |
Approximately 6-8 days |
| Hepatotoxicity |
None reported |
| Lab Test |
Growth Hormone levels |
| Main action |
Increases plasma levels of growth hormone |
| Side effects |
Irritation at injection site, water retention, tingling sensations, occasional dizziness |
| Storage conditions |
Should be refrigerated at 2-8 degrees Celsius, avoid freezing |
| Substance class |
Peptide hormone |
| Trade name |
Not available under a specific trade name |
| Use in sports |
Used to enhance performance and accelerate recovery |
| Water Retention |
Moderate |
| Active ingredient, mg |
5 |
| Release form |
Vial |
| 1 Ampoule, ml |
10 |
| Vials in the package, pcs |
1 |
| Manufacturer |
Peptide Sciences |
